OTC : APNHF
$0 (0.0%)
OTC
Stephen Bradley Saad
Drug Manufacturers - Specialty & Generic
Healthcare
APNHF
9557
ZA
USD
0.41
3.64
2.66
0.36
-0.47
$43.36B
1.68
0.80
14.65
9.95
-$2.44
-$1.08B
-5.19%
-5.59%
-2.41%
-1.56%
-32.37
0.31
0.31
0/5
0 Analysts
%
2.11
5/9
$41.28B
$127.18B
$46.64B
$9.07B
$92.15B
2.39
51.06
3.64
-2.41%
5.32%
-3.08%
6.82%
132 days
| Name | Title |
|---|---|
| Lorraine Hill | Group Chief Operations Officer |
| Raeesa Khan | Group Company Secretary & Chief of Staff |
| Sean Capazorio | Group Chief Financial Officer & Executive Director |
| Luresha Chetty | Corporate Affairs & Investor Relations Executive |
| Samer Kassem | Chief Executive Officer of Aspen Global Incorporated |
| Stephen Bradley Saad | Group Chief Executive Officer & Executive Director |
| Michael Guy Attridge | Group Chief Advisor |
| Reginald Haman PGDBA | Group Chief Corporate Officer |
| Sibongakonke Nkosi | Investor Relations Manager |
| Trevor Julian Ziman | Regional Chief Executive Officer of Asia Pacific |
No votes yet today — be the first to share your view!
About Aspen Pharmacare Holdings Limited (OTC:APNHF) Stock
Operating worldwide, Aspen Pharmacare Holdings Limited, together with its subsidiaries, focuses on the development, production, and global distribution of specialized and branded pharmaceutical products. The company's business activities are structured into two main divisions: Commercial Pharmaceuticals and Manufacturing. Under its Anaesthetics portfolio, Aspen offers diverse products such as general anesthetics, muscle relaxants, and topical agents. Its Thrombosis brand is dedicated to a variety of injectable anticoagulants, with an emphasis on low molecular weight heparins, Xa inhibitors, and heparin derivatives. Additionally, Aspen provides a range of branded consumer, prescription, and over-the-counter medications through regional brands. These include Circadin (for sleep management), ... Foxair (for respiratory conditions), Maltofer (an iron supplement), Mybulen (a painkiller), and Zyloric (which controls uric acid production). Beyond its proprietary offerings, the company also manufactures and supplies active pharmaceutical ingredients (APIs) and finished dosage form products to external clients. Founded in 1850, Aspen Pharmacare Holdings Limited is headquartered in Durban, South Africa.
Frequently Asked Questions
What is the current Aspen Pharmacare Holdings Limited (APNHF) stock price?
Aspen Pharmacare Holdings Limited(OTC:APNHF) stock price is $8.8 in the last trading session. During the trading session, APNHF stock reached the peak price of $8.8 while $6.23 was the lowest point it dropped to. The percentage change in APNHF stock occurred in the recent session was 0.0% while the dollar amount for the price change in APNHF stock was $0.
APNHF's industry and sector of operation?
The OTC listed APNHF is part of Drug Manufacturers - Specialty & Generic industry that operates in the broader Healthcare sector.
Who are the executives of APNHF?
Lorraine Hill
| Group Chief Operations Officer
Raeesa Khan
| Group Company Secretary & Chief of Staff
Sean Capazorio
| Group Chief Financial Officer & Executive Director
Luresha Chetty
| Corporate Affairs & Investor Relations Executive
Samer Kassem
| Chief Executive Officer of Aspen Global Incorporated
How many employees does APNHF have?
Number of APNHF employees currently stands at 9557. APNHF operates from Aspen Place, Durban, NL None, ZA.
Link for APNHF official website?
Official Website of APNHF is: https://www.aspenpharma.com
How do I contact APNHF?
APNHF could be contacted at phone #27 31 580 8600 and can also be accessed through its website. APNHF operates from Aspen Place, Durban, NL None, ZA.
How many shares of APNHF are traded daily?
The average number of APNHF shares traded daily for last 3 months was 4.
What is the market cap of APNHF currently?
The market value of APNHF currently stands at $3.91B with its latest stock price at $8.8